These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9807974)

  • 1. Gut motility and transit changes in patients receiving long-term methadone maintenance.
    Yuan CS; Foss JF; O'Connor M; Moss J; Roizen MF
    J Clin Pharmacol; 1998 Oct; 38(10):931-5. PubMed ID: 9807974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
    Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
    Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
    Yuan CS; Foss JF; O'Connor M; Osinski J; Karrison T; Moss J; Roizen MF
    JAMA; 2000 Jan; 283(3):367-72. PubMed ID: 10647800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6β-naltrexol, a peripherally selective opioid antagonist that inhibits morphine-induced slowing of gastrointestinal transit: an exploratory study.
    Yancey-Wrona J; Dallaire B; Bilsky E; Bath B; Burkart J; Webster L; Magiera D; Yang X; Phelps M; Sadee W
    Pain Med; 2011 Dec; 12(12):1727-37. PubMed ID: 22123184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
    Cheskin LJ; Chami TN; Johnson RE; Jaffe JH
    Drug Alcohol Depend; 1995 Aug; 39(2):151-4. PubMed ID: 8529534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of alcohol on gastrointestinal motility: lactulose breath hydrogen testing in orocecal transit time in chronic alcoholics, social drinkers and teetotaler subjects.
    Addolorato G; Montalto M; Capristo E; Certo M; Fedeli G; Gentiloni N; Stefanini GF; Gasbarrini G
    Hepatogastroenterology; 1997; 44(16):1076-81. PubMed ID: 9261602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effects of controlled release dihydrocodeine on oro-cecal transit and pupillary light reflex. A study in human volunteers.
    Freye E; Baranowski J; Latasch L
    Arzneimittelforschung; 2001 Jan; 51(1):60-6. PubMed ID: 11215327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath hydrogen as a test for gastrointestinal transit.
    Korth H; Müller I; Erckenbrecht JF; Wienbeck M
    Hepatogastroenterology; 1984 Dec; 31(6):282-4. PubMed ID: 6519639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of conventional treatment of chronic functional constipation on total and segmental colonic and orocecal transit times.
    Soares AC; Tahan S; Morais MB
    J Pediatr (Rio J); 2009; 85(4):322-8. PubMed ID: 19668908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
    Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine prolongs human small intestine transit time: use of the lactulose-breath hydrogen test.
    Rubinoff MJ; Piccione PR; Holt PR
    Am J Gastroenterol; 1989 Apr; 84(4):372-4. PubMed ID: 2929556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath hydrogen test after a bean meal demonstrates delayed oro-cecal transit time in children with chronic constipation.
    Soares AC; Lederman HM; Fagundes-Neto U; de Morais MB
    J Pediatr Gastroenterol Nutr; 2005 Aug; 41(2):221-4. PubMed ID: 16056103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit.
    Camboni G; Basilisco G; Bozzani A; Bianchi PA
    Dig Dis Sci; 1988 Dec; 33(12):1525-7. PubMed ID: 3197582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fasting gastrointestinal motility in the variability of gastrointestinal transit time assessed by hydrogen breath test.
    Di Lorenzo C; Dooley CP; Valenzuela JE
    Gut; 1991 Oct; 32(10):1127-30. PubMed ID: 1955166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
    Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
    Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lactulose hydrogen breath test as a measure of orocaecal transit time.
    Jorge JM; Wexner SD; Ehrenpreis ED
    Eur J Surg; 1994 Aug; 160(8):409-16. PubMed ID: 7811826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of gastrointestinal motility using the hydrogen breath test.
    Van Wyk M; Sommers DK; Steyn AG
    Br J Clin Pharmacol; 1985 Nov; 20(5):479-81. PubMed ID: 4074618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.